Jefferies Financial Group Analysts Give Fresenius SE & Co. KGaA (FRA:FRE) a €30.00 Price Target

Jefferies Financial Group set a €30.00 ($31.91) target price on Fresenius SE & Co. KGaA (FRA:FREGet Rating) in a research report report published on Monday morning, Borsen Zeitung reports.

FRE has been the subject of a number of other research reports. Deutsche Bank Rese… set a €36.00 ($38.30) price objective on Fresenius SE & Co. KGaA in a research report on Thursday, May 26th. Barclays set a €52.50 ($55.85) price objective on Fresenius SE & Co. KGaA in a research report on Tuesday, June 21st. UBS Group set a €30.00 ($31.91) price objective on Fresenius SE & Co. KGaA in a research report on Thursday, June 23rd. Berenberg Bank set a €60.25 ($64.10) price objective on Fresenius SE & Co. KGaA in a research report on Friday, April 29th. Finally, Deutsche Bank Aktiengesellschaft set a €36.00 ($38.30) price objective on Fresenius SE & Co. KGaA in a research report on Tuesday, March 1st.

Shares of FRA:FRE opened at €29.14 ($31.00) on Monday. Fresenius SE & Co. KGaA has a 52-week low of €60.16 ($64.00) and a 52-week high of €80.00 ($85.11). The stock has a 50 day moving average price of €31.98 and a 200-day moving average price of €33.51.

Fresenius SE & Co. KGaA Company Profile (Get Rating)

Fresenius SE & Co KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

Read More

Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.